NETANYA, Israel, Jan. 10, 2023 /PRNewswire/ — Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, today announced a strategic license and supply agreement with Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, for the exclusive marketing and distribution of FDA-approved Nerivio® in India, subject to completion of the regulatory approval process in India.
Read more here.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: https://blog.ourcrowd.com/theranica-enters-into-agreement-with-dr-reddys-for-commercializing-nerivio-in-india/
- 10
- 2023
- a
- advanced
- Agreement
- and
- announced
- approval
- company
- completion
- conditions
- developing
- Devices
- digital
- distribution
- Enters
- Exclusive
- Global
- HTML
- HTTPS
- in
- india
- Israel
- Jan
- License
- Ltd
- Marketing
- Newswire
- Other
- OurCrowd
- Pain
- Pharmaceutical
- plato
- Plato Data Intelligence
- PlatoData
- pr
- PR Newswire
- PRNewswire
- process
- regulatory
- regulatory approval
- Strategic
- subject
- supply
- The
- therapeutics
- to
- today
- zephyrnet